Tag: Ovarian

Search News
Categories
Archives
Mouse models of ovarian cancer

27th January 2020

Research led by the Barts Cancer Institute, Queen Mary University of London, has revealed that mouse models of the most common and deadly form of ovarian cancer, high-grade serous ovarian cancer, can effectively replicate the disease in humans. These models provide useful pre-clinical tools that may help to determine which patients are likely to respond to particular treatments.

Read more

BRCA testing for higher risk group

13th September 2019

Researchers are calling for population-wide BRCA testing in the Jewish community after finding it to be more effective than current approaches, cost effective and to have a high satisfaction rate with those undergoing testing.

Read more

Resistance in Ovarian Cancer

13th March 2019

Ovarian Cancer Awareness Month This month is Ovarian Cancer Awareness Month. In the UK each year, around 7,300 women are diagnosed with ovarian cancer, making it the sixth most common cancer type in females. Here at the Barts Cancer Institute, our researchers are working to better understand the biology of ovarian cancer and translate this knowledge into […]

Read more

NHS Innovation Accelerator

5th March 2019

Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts Health NHS Trust, was announced today as one of 13 Fellows to join the NHS Innovation Accelerator (NIA), which supports dedicated individuals to scale their high impact, evidence-based innovations across the NHS and wider healthcare system. Dr Manchanda’s innovation is a […]

Read more

Research suggests improved detection rates are needed to maximise cancer prevention

8th June 2018

Current detection strategies are found to have identified only 2.6% of the BRCA gene mutation carriers in the Greater London population, according to a recent study published in the Journal of Medical genetics. The findings of the study, performed by researchers from the BCI’s Centre for Experimental Cancer Medicine, led by Dr Ranjit Manchanda, suggest that enhanced and new approaches are required to maximise the opportunity for breast and ovarian cancer prevention.

Read more

Dr Ranjit Manchanda awarded William Blair Bell Memorial Lecture

9th March 2018

Congratulations to our Dr Ranjit Manchanda, Centre for Experimental Cancer Medicine, who has been awarded the William Blair Bell Memorial Lecture prize. Dr Ranjit Manchanda was awarded with the prize on 8th February and presented his lecture, entitled ‘Population based germline testing and targeted ovarian cancer prevention,’ the following day.

Read more

Search News
Categories
Archives
Upcoming Events
  1. The London Pancreas Workshop 2020

    May 1 @ 9:30 am - 4:30 pm
  2. 2020 Circulating Cancer Biomarker Symposium

    May 4 @ 9:00 am - 5:30 pm
© 2013 ~ 2020 Cancer Research UK Barts Centre